Literature DB >> 16169782

Ischaemic jejunal vasculitis during treatment with pegylated interferon-alpha 2b and ribavirin for hepatitis C virus related cirrhosis.

M Pompili1, F Pizzolante, L M Larocca, M Covino, G L Rapaccini, G Gasbarrini.   

Abstract

A 53-year-old male with compensated cirrhosis (Child-Pugh class A5) and mixed cryoglobulinaemia (cryocrit: 2.0%), both hepatitis C virus-related, was treated with pegylated interferon-alpha 2b and ribavirin. After three months of therapy, he developed segmental jejunal vasculitis requiring emergency resection of an ischaemic intestinal loop 60cm long. Pathological examination of the surgical specimen revealed signs of ischaemic injury with haemorrhagic infarction due to arteritis and arterial occlusion. The postoperative course was complicated by progressive liver and renal failure that led to the patient's death six months after surgery. To our knowledge, ischaemic jejunal vasculitis has never been reported during interferon therapy, but the latter treatment may have played causative roles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16169782     DOI: 10.1016/j.dld.2005.07.008

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  2 in total

1.  Digital ischemic necrosis caused by pegylated interferon in a patient with hepatitis C.

Authors:  Jana G Hashash; Sean A Tackett; David J McAdams
Journal:  World J Gastrointest Pharmacol Ther       Date:  2011-02-06

Review 2.  Treatment of hepatitis C virus infection and associated vascular complications: a literature review.

Authors:  Reza Karbasi-Afshar
Journal:  Iran J Med Sci       Date:  2014-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.